SI-BONE Q3 revenue $48.7M (+20.6% YoY), raises FY2025 guidance

SI-BONE, Inc.

2025-Q3 EPS reported -$0.40 vs consensus -$0.17 ▼ miss (-136.1%)

Net loss improved to $4.6M ($0.11/share) from $6.6M ($0.16) a year ago.
U.S. revenue $46.4M (+21.2% YoY); gross margin 79.8% (+75 bps); operating cash flow positive $2.3M.
FY2025 revenue guidance raised to $198M-$200M (from $195M-$198M), implying ~18-20% growth.
Adjusted EBITDA positive $2.3M vs loss $0.2M; cash and equivalents $145.7M.
Director Daniel Wolf resigned; Thomas West appointed to Audit Committee; Wolf to consult 12 months, 8,675 RSUs accelerated.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.